Overview

Update
Status
Acquired by on August 5, 2013
Total Equity Funding
$33M in 3 Rounds from 2 Investors
Headquarters:
Leiden
Description:
ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.
Founders:
Categories:
Pharmaceutical, Biopharma, Biotechnology
Website:
http://www.profibrix.com
Social:

Company Details

Update

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004

Funding Rounds (3) - $33M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2011$10.6M / Series B2
Aug, 2009$11.4M / Series B1
Mar, 2007$11M / Series A1

Investors (2)

InvestorRound(s)Partner(s)
Series B (Lead)
Series B (Lead)-
Series A (Lead)-
Series B (Lead)-

Current Team (1)

Update

News (5)

Update
DateNews
Aug 6, 2013Fierce Biotech - Medicines Co. wraps $240M deal to buy ProFibrix following PhIII success
Aug 4, 2011OnBioVC - ProFibrix raises 10600000 in venture round
Sep 28, 2009dealipedia.com - ProFibrix raises 11400000 in venture round
Aug 24, 2009Xconomy - ProFibrix Closes $11M Series B
Mar 27, 2007PE HUB - PE HUB

Offices/Locations (1)

Update
  • HQ

    Zernikedreef 9

    Leiden, 2333

    NLD

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos